{"id":30167,"date":"2023-04-04T05:00:29","date_gmt":"2023-04-04T05:00:29","guid":{"rendered":"http:\/\/myanmarnewswire.com\/?guid=9ab7bd2d82c1b83db7865b351ebeab37"},"modified":"2023-04-04T05:00:29","modified_gmt":"2023-04-04T05:00:29","slug":"correction-evident-acquired-by-bain-capital-partnership-to-accelerate-future-growth-and-innovation","status":"publish","type":"post","link":"https:\/\/myanmarnewswire.com\/correction-evident-acquired-by-bain-capital-partnership-to-accelerate-future-growth-and-innovation\/","title":{"rendered":"CORRECTION \u2013 Evident Acquired by Bain Capital: Partnership to Accelerate Future Growth and Innovation"},"content":{"rendered":"
TOKYO, April 03, 2023 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Evident Corporation, please note that the titles of Yuji Sugimoto and Stephen Thomas have been corrected to Partner, and the spelling of Stephen Thomas\u2019s name has been revised. The corrected release follows:<\/p>\n
Evident Corporation (\u201cEvident\u201d) announced today that it has been acquired by private equity firm Bain Capital Private Equity (\u201cBain Capital\u201d) from Olympus Corporation (\u201cOlympus\u201d) pursuant to the definitive agreement signed on August 29, 2022.<\/p>\n
Evident was newly established on April 1, 2022 as a wholly owned subsidiary of Olympus comprising the former Scientific Solutions business conducted by Olympus. Headquartered in Tokyo, Japan, Evident conducts business in 24 countries worldwide with more than 4,300 employees.<\/p>\n
Supported by Bain Capital, Evident will attain a higher level of agility and faster decision-making to drive innovation-based growth in the life science and industrial markets. Building on a history of more than 100 years of innovation in imaging, instrumentation, and measurement solutions, Evident plans to further expand its portfolio of world-class products, solutions, and services.<\/p>\n
Yoshitake Saito, the President and CEO of Evident said \u201cWe are very excited about our partnership with Bain Capital because we are convinced that it will enable us to even more strongly fulfill our purpose of becoming a preferred workflow solution partner for a broad range of customers in the life science and industrial markets.\u201d<\/p>\n
Yuji Sugimoto, Partner of Bain Capital in Japan, said \u201cBain Capital is committed to supporting Evident on its sustainable growth path to allow the company to foster an accelerated innovation process.\u201d<\/p>\n
Stephen Thomas, Partner of Bain Capital in North America, added \u201cEvident is at the frontier of digital optical technology in the life science and industrial end markets, and has great potential to expand into new products, new customers, and new markets as an independent company.\u201d<\/p>\n
About EVIDENT<\/u><\/strong><\/p>\n At Evident, we are guided by the scientific spirit\u2014innovation and exploration are at the heart of what we do. Committed to making people\u2019s lives healthier, safer, and more fulfilling, we support our customers with solutions that solve their challenges and advance their work\u2014whether it\u2019s researching medical breakthroughs, inspecting infrastructure, or exposing hidden toxins in consumer products.<\/p>\n Evident Industrial\u2019s solutions range from microscopes and videoscopes to nondestructive testing equipment and X-ray analyzers for maintenance, manufacturing, and environmental applications. Backed by state-of-the-art technologies, Evident\u2019s products are widely used for quality control, inspection, and measurement.<\/p>\n Evident Life Science empowers scientists and researchers through collaboration and cutting-edge life science solutions. Dedicated to meeting the challenges and supporting the evolving needs of its customers, Evident Life Science advances a comprehensive range of microscopes for pathology, hematology, IVF, and other clinical applications as well as for research and education.<\/p>\n